X

Health & Biotech

ASX Health Stocks: Recce can now dose R327 at higher level, testing its high concentration potential

Recce Pharma cleared to increase R327's minimum dose. R327 can now be administered at 4,000mg over a fast infusion of…

Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners

There's been a breakthrough in acne treatment. Scientists have found a way to use skin bacteria to control sebum production.

Cash balance boom: EZZ reports strong quarter with progress on all fronts

EZZ Life Science has reported receipts from customers of $23.6m for Q3 FY24, up 111% on the prior corresponding period,…

ScoPo’s Powerplays: Nowhere to hide as ASX health stocks tumble in broader selloff

ASX health stocks fall in past five days in line with broader markets as ResMed (ASX:RMD) feels more heat from…

Paradigm makes key submission to US FDA to advance osteoarthritis Phase 3 trial

Paradigm Biopharmaceuticals has submitted key documents to the US Food and Drug Administration (FDA) for review, aiming to advance its…

ASX Health Stocks: Paradigm responds to US FDA, seeks marketing approval from TGA

Paradigm Biopharma submits response to the FDA. INOVIQ says its blood test on ovarian cancer is highly accurate.

ASX Health Stocks: Immutep hooks leading research firm CHDR to conduct Phase 1 drug study

Immutep teams up with CHDR for landmark human study of IMP761 in autoimmune diseases. Next Science's XPERIENCE proven effective.

PharmAust bolsters manufacturing leadership to expand path to commercialisation

Leading clinical stage biotech PharmAust has marked a significant milestone in its journey towards commercialisation of its lead drug monepantel…

Which ASX companies are resurrecting abandoned drugs? Part 3

Paradigm Pharmaceuticals (ASX:PAR) has identified the potential of PPS, an FDA-approved drug to treat osteoarthritis.

Weed Week: A VAST majority of Americans now want marijuana to be legal

Where are we in terms of US legalisation of cannabis? What about the current legal landscape for cannabis in Australia?